Foetal growth restriction;Vekstretardasjon hos fosteret

Tidsskrift for den Norske Laegeforening

Volumn 127, Issue 20, 2007, Pages 2665-2669

  Haram, Kjell ^a   Gjelland, Knut ^a  

^a Kvinneklinikken   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; BIRTH WEIGHT; ECHOGRAPHY; FEMALE; FETUS MONITORING; HUMAN; INTRAUTERINE GROWTH RETARDATION; NEWBORN; PREGNANCY; PREGNANCY COMPLICATION; PREMATURE LABOR; REFERENCE VALUE; REVIEW; RISK FACTOR;

ADULT; BIRTH WEIGHT; FEMALE; FETAL GROWTH RETARDATION; FETAL MONITORING; HUMANS; INFANT, NEWBORN; OBSTETRIC LABOR, PREMATURE; PREGNANCY; PREGNANCY COMPLICATIONS; REFERENCE VALUES; RISK FACTORS; ULTRASONOGRAPHY, PRENATAL;

EID: 35848943663     PISSN: 00292001     EISSN: 08077096     Source Type: Journal    
DOI: None     Document Type: Article

References (57)

1. Manning FA. Intrauterine growth retardation. I: Manning FA, red. Fetal medicine: Principles and practice. Norwalk, CT: Apelton and Lange, 1995: 307-93.
2. Lin CC, Santolaya-Forgas J. Current concepts of fetal growth restriction: part I. Causes, classification, and pathophysiology. Obstet Gynecol 1998; 92: 1044-55.
3. Resnik R. Intrauterine growth restriction. Obstet Gynecol 2002; 99: 490-6.
4. Brodszki J, Hernandez-Andrade E, Gudmundsson S et al. Can the degree of retrograde diastolic flow in abnormal umbilical artery flow velocity waveforms predict pregnancy outcome? Ultrasound Obstet Gynecol 2002; 19: 229-34.
5. Cunningham FG, Cox SM, Harstad TW et al. Chronic renal disease and pregnancy outcome. Am J Obstet Gynecol 1990; 163: 453-9.
6. Eslick GD, Yan P, Xia HH et al. Foetal intrauterine growth restrictions with Helicobacter pylori infection. Aliment Pharmacol Ther 2002; 16: 1677-82.
7. Gilbert GL. 1: Infections in pregnant women. Med J Aust 2002; 176: 229-36.
8. Howley HE, Walker M, Rodger MA. A systematic review of the association between factor V Leiden or prothrombin gene variant and intrauterine growth restriction. Am J Obstet Gynecol 2005; 192: 694-708.
9. Khan NA, Kazzi SN. Yield and costs of screening growth-retarded infants for torch infections. Am J Perinatol 2000; 17: 131-5.
10. Knox GE. Influence of infection on fetal growth and development. J Reprod Med 1978; 21: 352-8.
11. Long PA, Abell DA, Beischer NA. Fetal growth retardation and pre-eclampsia. Br J Obstet Gynaecol 1980; 87: 13-8.
12. Neggers YH, Goldenberg RL, Tamura T et al. The relationship between maternal dietary intake and infant birthweight. Acta Obstet Gynecol Scand Suppl 1997; 165: 71-5.
13. Nilsen ST, Sagen N, Kim HC et al. Smoking, hemoglobin levels, and birth weights in normal pregnancies. Am J Obstet Gynecol 1984; 148: 752-8.
14. Offenbacher S, Lieff S, Boggess KA et al. Maternal periodontitis and prematurity. Part I: Obstetric outcome of prematurity and growth restriction. Ann Periodontol 2001; 6: 164-74.
15. Pollack RN, Divon MY. Intrauterine growth retardation: definition, classification, and etiology. Clin Obstet Gynecol 1992; 35: 99-107.
16. Rasmussen S, Irgens LM. Fetal growth and body proportion in preeclampsia. Obstet Gynecol 2003; 101: 575-83.
17. Rasmussen S, Irgens LM. The effects of smoking and hypertensive disorders on fetal growth. BMC Pregnancy Childbirth 2006; 6: 16.
18. Scanlon KS, Yip R, Schieve LA et al. High and low hemoglobin levels during pregnancy: differential risks for preterm birth and small for gestational age. Obstet Gynecol 2000; 96: 741-8.
19. Scholl TO, Hediger ML, Fischer RL et al. Anemia vs iron deficiency: increased risk of preterm delivery in a prospective study. Am J Clin Nutr 1992; 55: 985-8.
20. Zulman JI, Talal N, Hoffman GS et al. Problems associated with the management of pregnancies in patients with systemic lupus erythematosus. J Rheumatol 1980; 7: 37-49.
21. Craigo SD. The role of ultrasound in the diagnosis and management of intrauterine growth retardation. Semin Perinatol 1994; 18: 292-304.
22. Abdel-Fattah SA, Bhat A, Illanes S et al. TORCH test for fetal medicine indications: only CMV is necessary in the United Kingdom. Prenat Diagn 2005; 25: 1028-31.
23. Shulman CE, Dorman EK. Importance and prevention of malaria in pregnancy. Trans R Soc Trop Med Hyg 2003; 97: 30-5.
24. Ekbom P, Damm P, Feldt-Rasmussen B et al. Pregnancy outcome in type 1 diabetic women with microalbuminuria. Diabetes Care 2001; 24: 1739-44.
25. Gabbe SG. Intrauterine growth retardation. I: Gabbe SG, Niebyl JR, Simpson JL, red. Obstetrics. Normal and problem pregnancies. New York: Churchill Livingstone, 1991: 923-44.
26. McElvy SS, Demarini S, Miodovnik M et al. Fetal weight and progression of diabetic retinopathy. Obstet Gynecol 2001; 97: 587-92.
27. Skomsvoll JF, Ostensen M, Irgens LM et al. Perinatal outcome in pregnancies of women with connective tissue disease and inflammatory rheumatic disease in Norway. Scand J Rheumatol 1999; 28: 352-6.
28. Mintz G, Niz J, Gutierrez G et al. Prospective study of pregnancy in systemic lupus erythematosus. Results of a multidisciplinary approach. J Rheumatol 1986; 13: 732-9.
29. Spinillo A, Capuzzo E, Baltaro F et al. The effect of work activity in pregnancy on the risk of fetal growth retardation. Acta Obstet Gynecol Scand 1996; 75: 531-6.
30. Armant DR, Saunders DE. Exposure of embryonic cells to alcohol: contrasting effects during preimplantation and postimplantation development. Semin Perinatol 1996; 20: 127-39.
31. Bateman DA, Chiriboga CA. Dose-response effect of cocaine on newborn head circumference. Pediatrics 2000; 106: E33.
32. Fulroth R, Phillips B, Durand DJ. Perinatal outcome of infants exposed to cocaine and/or heroin in utero. Am J Dis Child 1989; 143: 905-10.
33. Kuhn L, Kline J, Ng S et al. Cocaine use during pregnancy and intrauterine growth retardation: new insights based on maternal hair tests. Am J Epidemiol 2000; 152: 112-9.
34. Churchill D, Bayliss H, Beevers G. Fetal growth restriction. Lancet 2000; 355: 1366-7.
35. Little BB. Immunosuppressant therapy during gestation. Semin Perinatol 1997; 21: 143-8.
36. Prevot A, Martini S, Guignard JP. In utero exposure to immunosuppressive drugs. Biol Neonate 2002; 81: 73-81.
37. Isaksen CV, Laurini RN, Jacobsen G. Pre-pregnancy risk factors of small-for-gestational-age births and perinatal mortality. Acta Obstet Gynecol Scand Suppl 1997; 165: 44-9.
38. Elgen I, Sommerfelt K, Markestad T. Population based, controlled study of behavioural problems and psychiatric disorders in low birthweight children at 11 years of age. Arch Dis Child Fetal Neonatal Ed 2002; 87: F128-32.
39. Sallout B, Walker M. The fetal origin of adult diseases. J Obstet Gynaecol 2003; 23: 555-60.
40. Sommerfelt K, Troland K, Ellertsen B et al. Behavioral problems in low-birthweight preschoolers. Dev Med Child Neurol 1996; 38: 927-40.
41. Geirsson RT. Ultrasound instead of last menstrual period as the basis of gestational age assignment. Ultrasound Obstet Gynecol 1991; 1: 212-9.
42. Kiserud T, Servoll T. Symfyse-fundusmåling som ledd i svangerskapskontrollen. Tidsskr Nor Lægeforen 1982; 102: 243-5.
43. Jacobsen G. Prediction of fetal growth deviations by use of symphysis-fundus height measurements. Int J Technol Assess Health Care 1992; 8 (suppl 1): 152-9.
44. Lin CC, Santolaya-Forgas J. Current concepts of fetal growth restriction: part II. Diagnosis and management. Obstet Gynecol 1999; 93: 140-6.
45. Altman DG, Chitty LS. New charts for ultrasound dating of pregnancy. Ultrasound Obstet Gynecol 1997; 10: 174-91.
46. Johnsen SL, Rasmussen S, Sollien R et al. Fetal age assessment based on ultrasound head biometry and the effect of maternal and fetal factors. Acta Obstet Gynecol Scand 2004; 83: 716-23.
47. Pardey J, Moulden M, Redman CW. A computer system for the numerical analysis of nonstress tests. Am J Obstet Gynecol 2002; 186: 1095-103.
48. Kiserud T, Eik-Nes SH, Blaas HG et al. Ductus venosus blood velocity and the umbilical circulation in the seriously growth-retarded fetus. Ultrasound Obstet Gynecol 1994; 4: 109-14.
49. Mari G, Deter RL. Middle cerebral artery flow velocity waveforms in normal and small-for-gestational-age fetuses Am J Obstet Gynecol 1992; 166: 1262-70.
50. Kiserud T, Maršál K. Ultrasound assessment. I: Kingdom J, Baker P, red. Intrauterine growth restriction. Aetiology and management. London: Springer, 2000: 205-38.
51. Haram K, Softeland E, Bukowski R. Intrauterine growth restriction. Int J Gynaecol Obstet 2006; 93: 5-12.
52. Neilson JP. Cochrane Update: antenatal corticosteroids for accelerating fetal lung maturation for women at risk of preterm birth. Obstet Gynecol 2007; 109: 189-90.
53. Illanes S, Soothill P. Management of fetal growth restriction. Semin Fetal Neonatal Med 2004; 9: 395-401.
54. Neilson JP. Fetal electrocardiogram (ECG) for fetal monitoring during labour. Cochrane Database Syst Rev 2006; 3: CD000116.
55. Baschat AA. Arterial and venous Doppler in the diagnosis and management of early onset fetal growth restriction. Early Hum Dev 2005; 81: 877-87.
56. Madazli R, Uludag S, Ocak V. Doppler assessment of umbilical artery, thoracic aorta and middle cerebral artery in the management of pregnancies with growth restriction. Acta Obstet Gynecol Scand 2001; 80: 702-7.
57. Ojala K, Vaarasmaki M, Makikallio K et al. A comparison of intrapartum automated fetal electrocardiography and conventional cardiotocography - a randomised controlled study. BJOG 2006; 113: 419-23.